Registration for this event is handled by RegOnline. Please use the link below to proceed to the appropriate registration page(s).
$950.00 registration fee for all attendees for 2014 courses.
The full fee is payable in advance and includes all course materials. Early registration is advised because of limited enrollment for each course.
A request must be submitted in writing and faxed to 803-434-4354. Please include the name of the registrant, your contact information, dates of the training course and the method of payment used. Refunds will be issued as follows:
|Cancellation Date||Refund Amount|
|21 days prior to course:||100% minus $85.00* fee|
|14 days prior to course:||50% minus $85.00* fee|
|Less than 14 days or no show:||No Refund|
|*(includes $50.00 processing fee and $35.00 chargeback fee)|
Thank you for your interest in our Hyperbaric Medicine Program. Please contact email@example.com with further questions. We look forward to your attendance.
A room block has been arranged at the Marriott Springhill Suites in the Vista. Special rates starting at $124 a night for 2014 are offered to registered attendees, for single or double occupancy. The Marriott Springhill Suites will provide airport transportation and daily transportation to and from the hospital for the days of the training course at no additional cost. Complimentary breakfast will be included per night. Wireless internet and self-parking are also provided at no charge.
It is your responsibility to make hotel reservations directly by contacting our the Marriott Springhill Suites directly at the link below.
|To secure accommodation for the course week of:||Hotel reservations must be made by:|
|December 8-12, 2014||November 17, 2014|
The clinical utilization of alterations in atmospheric pressure dictate that the practitioner comprehend both the beneficial and potentially hazardous aspects of this esoteric environment. Applicable gas laws and their role in hyperbaric medicine will be reviewed.
Under increased atmosphere pressure, oxygen becomes a potent and dose dependent drug. Six beneficial effects have been identified: hyperoxygenation, vasoconstriction, superoxide radical formation, pressure/volume related effects, neovascularization and antagonism of leukocyte induced reperfusion injury. The scientific elucidation of these mechanisms and their clinical relevance are discussed.
Special emphasis will be placed upon the preparation of the patient for hyperbaric oxygen therapy. The typical emergent referral involves a patient who is incubated, ventilator dependent, with peripheral and central vascular access lines and the possibility of a chest tube. Each of these aspects, as they relate to relative patient isolation and alterations in atmospheric pressure, will be discussed and practiced. Risk factors for hyperbaric oxygen exposure will be clarified and the management of patient complications reviewed in detail.
As a gaseous drug, large doses of oxygen can produce undesirable side effects and drug interactions. The central nervous system and lungs are two most commonly effected organs and their response to hyperbaric oxygen will be reviewed in depth. Special emphasis will be placed on the recognition and management of CNS oxygen toxicity.
Through a cohesive series of clinical training sessions, the prospective hyperbaric team member will learn and participate in all aspects of the monoplace hyperbaric chamber delivery system. Standard operational protocols will be augmented with ancillary equipment demonstrations and a detailed review of emergency procedures.
Pre-exposure evaluation of risk factors centers around the prevention of pulmonary barotrauma of ascent and the development of a central nervous system oxygen intolerance secondary to high inspired oxygen pressures. The risk-benefit ratio will be discussed, and in the context of the full range of patient states.
Boyle’s law dictates that the volume of a gas is inversely proportional to the pressure exerted upon it. Specifically, the clinical ramifications of this simple principle as it relates to gas bearing anatomy will be discussed. The effects of pressure changes in the middle ear will be examined in detail, and the technical considerations of needle myringotomy will be detailed.
Carbon monoxide is the most common cause of poisoning in the U.S. In its subtle form the diagnosis is easily missed. A new appreciation for the phenomenon of clinical relapse following conventional oxygen therapy and the potential for long term sequelae has reshaped our understanding of this toxic gas. Current concepts in the pathophysiology of the disease are explored and will include the role of hyperbaric oxygen therapy in pregnancy.
This occupational disease of divers, aviators and tunnel workers is no longer limited in presentation to coastal regions and military institutions. Decompression sickness can result from exposure to any body of water deeper than 30 feet. With more divers flying to and from their dive sites, the potential for illness must be considered, regardless of geographic location. Differential diagnosis, on-site management, evacuation protocols and definitive therapy will be discussed, as will the capabilities of the monoplace chamber.
A major life-threatening event, cerebral arterial gas embolization can occur during decompression (in divers and aviators), traumatically in penetrating chest injuries and, most commonly, in the clinical setting secondary to invasive diagnostic, monitoring, or therapeutic procedures. Presentation, differential diagnosis and management guidelines will be reviewed.
In an earlier report, it was found that when hyperbaric oxygen therapy was used to arrest the progression of a skeletal compartment syndrome, the cost of management was one-fourth that of surgically treated compartment syndromes. While not proposed in severe cases, the use of HBO in compartment syndrome in selected cases is based on its ability to down-regulate leukocyte receptor sites, decrease tissue edema, hyperoxygenate tissue and overcome diffusion barriers. Evidence for its role in the management of crush injuries is reviewed in detail.
Anaerobic infections are among the most challenging infectious disease problems. Optimum management in many instances mandates a combined therapeutic regimen using antibiotics and surgery in combination with hyperbaric oxygen. There is a growing body of evidence to indicate that HBO provides a number of benefits, which include detoxification of the patient, enhanced white cell activity, a synergistic enhancement of selected antibiotics, and improved wound healing.
The therapy of burns is directed a minimizing edema, preserving marginally viable tissue, enhancing host defenses and promoting wound closure. Adjunctive hyperbaric oxygen can attack all of these problems directly through a combination of mechanisms. Basic research, controlled clinical studies and cost impact will be reviewed.
It was the consensus of the 1990 National Cancer Institute Conference on Oral Complications of Cancer Therapies that HBO is a standard of care, in conjunction with surgery as indicated, for osteoradionecrosis of the mandible. Further, HBO was recommended in a prophylactic capacity prior to surgical procedures within the irradiated field, in high risk patients. Evidence of a benefit of HBO in soft tissue radiation injury will be included during this presentation.
While not indicated for the support of adequately perfused tissue, hyperbaric oxygen can play an important adjunctive role where hypoxia or decreased microcirculatory flow complicates wound healing. In the compromised host setting, HBO can restore a favorable cellular milieu in which the wound repair process and host antibiotic mechanisms are enhanced. The role of HBO in diabetic foot lesions will be emphasized.
Drawing upon the orthopedic and vascular surgery literature, a number of indicators have served to both predict outcome from various procedures and determine the degree of severity in vascular disease. One particular aspect, tissue oxygen tension , as measured trancutaneously, has been introduced into the hyperbaric oxygen setting as a indicator of the ability to reverse local hypoxia. An algorithmic screening and case-management protocol will be introduced.
Interesting clinical problems and case illustrations will be presented. Cases have been selected which will emphasize key management principles.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Undersea & Hyperbaric Medical Society (UHMS) and National Baromedical Services, Inc. The UHMS is accredited by the ACCME to provide continuing medical education for physicians.
All faculty members and planners participating in continuing medical education activities sponsored by National Baromedical Services, Inc. are expected to disclose to the participants any relevant financial relationships with commercial interests. Full disclosure of faculty and planner relevant financial relationships will be made at the activity.
UHMS Disclaimer: As this course's Joint Sponsor, the Undersea and Hyperbaric Medical Society, Inc (UHMS) provides only administrative approval for the Continuing Medical Education (CME) aspects of this course. Consequently, the approaches, views, statements, and opinions expressed in the lectures and materials being presented are those of the course's authors, lecturers and director(s) and do not necessarily represent those of the UHMS. A detailed description of UHMS course sponsor relationships is available on the UHMS website at http://membership.uhms.org/?page=CMESponsorship.
Attendance is limited to 36 attendees. Each course is generally filled to capacity within six weeks of the starting date. Therefore, if you plan to attend, we encourage you to register early to secure the dates of your choice.
Telephone requests will not hold your training course reservation. Online registration including advance payment is required to secure your reservation. Once registration is complete you will receive an email confirmation.
A Primary Training in Hyperbaric Medicine course certificate is provided only at the completion of the entire 40 hours of training. Participants MUST be in attendance the entire week. Please arrange departure flights no earlier than 1:30 PM EST on the last day of the course. Attendees who leave prior to the completion of the course are not eligible to receive a course completion certificate.
The Undersea and Hyperbaric Medical Society designates this educational activity for a maximum of 40 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Undersea & Hyperbaric Medical Society (UHMS) and National Baromedical Services, Inc. The UHMS is accredited by the ACCME to provide continuing medical education for physicians.
National Baromedical Services provides both Primary and Advanced hyperbaric medicine training programs. Courses are taught on the campus of Palmetto Health Richland/University of South Carolina School of Medicine, in Columbia, South Carolina.
Over the past two decades, we have evolved into the busiest such training center, with more than 6,000 course attendees. Approximately 400 physicians, nurses, technologists and other allied health care professionals visit Columbia each year, from throughout the United States and from overseas. Our courses are accredited by the: